🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-22
Trial ID
NCT00289783
Thanks to improved surgical techniques, postoperative management and immuno...
Status
Completed
Location
Hospices Civils de Lyon
Start Date
2016-01-01
Trial ID
NCT03180359
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
If your serious vaccine-induced adverse event has been entered in the CDC V...
Status
Unknown
Location
Neuroganics LLC
Start Date
2022-03-15
Trial ID
NCT05095844
Treatments Being Tested
This clinical trial will evaluate the safety of two injections of Menactra®...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00483574
The main target populations for the tetravalent live attenuated dengue viru...
Status
Completed
Location
USAMC-AFRIMS/Department of Pediatrics, Pharamongkutklao Hospital
Start Date
2004-02
Trial ID
NCT00322049